Frequently Asked Questions
The market is segmented based on , By Type (45S5, S53P4, and Others), Application (Orthopaedics, Dentistry, Cosmetics, and Others), Industry Vertical (Medical, Dental, and Cosmetics), Synthesis Process (Melt Quench Synthesis, Sol-Gel Synthesis, and Microwave Synthesis), Product (Granules, Powders, and Nano-Powders) – Industry Trends and Forecast to 2031.
.
The Global Bioactive Glass Market size was valued at USD 25.10 USD Billion in 2023.
The Global Bioactive Glass Market is projected to grow at a CAGR of 6.43% during the forecast period of 2024 to 2031.
The major players operating in the market include Arthrex, Inc. (U.S.), NORAKER (France), SCHOTT AG (Germany), Stryker (U.S.), Bonalive Biomaterials Ltd. (Finland), British Glass Manufacturers' Confederation (U.K.), MO SCI, LLC (U.S.), LASAK s.r.o. (Czech Republic), Synergy Biomedical, LLC (U.S.), Medical Device Business Services, Inc. (U.S.), MATEXCEL (India), Medtronic (Ireland), NanoFUSE Biologics (U.S.), 3M (U.S.), and Merck KGaA (Germany).
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, United Arab Emirate, Saudi Arabia, Egypt, Israel, South Africa, Rest of Middle East and Africa.
